Agüera-Morales, E., Fernández-Sánchez, V., Navarro-Mascarell, G., Cabezas-Rodríguez, J., Peña-Toledo, M., Reyes-Rodríguez, V., . . . Fernández-Fernández, O. (2025). Adipose-derived mesenchymal stem cells for the treatment of amyotrophic lateral sclerosis. A phase I/II safety and efficacy clinical trial.
Chicago Style CitationAgüera-Morales, E., et al. Adipose-derived Mesenchymal Stem Cells for the Treatment of Amyotrophic Lateral Sclerosis. A Phase I/II Safety and Efficacy Clinical Trial. 2025.
MLA CitationAgüera-Morales, E., et al. Adipose-derived Mesenchymal Stem Cells for the Treatment of Amyotrophic Lateral Sclerosis. A Phase I/II Safety and Efficacy Clinical Trial. 2025.
Warning: These citations may not always be 100% accurate.